image

The best stocks to buy since 1993

Latest issue now available

Tarsus - Buys fast growing anti-ageing exhibition

December 2006

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRS
  • Price:
  • 230p
One standout piece of news this month was that tradeshow owner and organiser Tarsus (230p; TRS) finally completed the substantial acquisition of MCII, operator of the leading anti-ageing exhibition in the US. We first tipped Tarsus in Nov '04 and even though the shares have doubled since, the growth has largely come from organic roll out of its labelling and discount exhibitions in the emerging markets and also some small acquisitions in France. As Tarsus' managing director, Douglas Emslie, points out, the acquisition of MCII adds an exciting new leg in medical events if it goes according to plan, and on reasonable assumptions, profits could almost double over the next three years. MCII operates three big events in Orlando (April) ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe